Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

404 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study.
Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Geusens P, et al. Arthritis Rheum. 1994 Jun;37(6):824-9. doi: 10.1002/art.1780370608. Arthritis Rheum. 1994. PMID: 8003055 Clinical Trial.
A 12-week randomized, double-blind, placebo-controlled multicenter study of choline-stabilized orthosilicic acid in patients with symptomatic knee osteoarthritis.
Geusens P, Pavelka K, Rovensky J, Vanhoof J, Demeester N, Calomme M, Vanden Berghe D. Geusens P, et al. BMC Musculoskelet Disord. 2017 Jan 5;18(1):2. doi: 10.1186/s12891-016-1370-7. BMC Musculoskelet Disord. 2017. PMID: 28056936 Free PMC article. Clinical Trial.
Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, Adams S, Broos P, Lenaerts J, Raus J, Vanderschueren D, Geusens P. Boonen S, et al. Among authors: geusens p. J Clin Endocrinol Metab. 2002 Apr;87(4):1593-9. doi: 10.1210/jcem.87.4.8426. J Clin Endocrinol Metab. 2002. PMID: 11932288 Clinical Trial.
Placebo-treated patients, on the other hand, failed to regain lost bone: at 6 months postfracture, bone density in the placebo group had declined by 6.1% (P = 0.04). Additionally, in patients treated with 1.0 mg/kg.d rhIGF-I/IGFBP-3, grip strength had increased from baseli …
Placebo-treated patients, on the other hand, failed to regain lost bone: at 6 months postfracture, bone density in the placebo group had dec …
Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P. Pauwels RA, et al. Among authors: geusens p. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):827-32. doi: 10.1164/ajrccm.157.3.9610009. Am J Respir Crit Care Med. 1998. PMID: 9517598 Clinical Trial.

During the 1-mo run-in period, bronchodilators were replaced by salmeterol 50 microg twice daily, increasing morning peak expiratory flow rate (PEFR) by 28 L/min (p < 0.001) and FEV1 by 6.2% predicted (p < 0.001). ...Osteocalcin and bone mineral density (BMD)

During the 1-mo run-in period, bronchodilators were replaced by salmeterol 50 microg twice daily, increasing morning peak expiratory flow ra …
Treatment of established osteoporosis and rehabilitation: current practice and possibilities.
Dequeker J, Geusens P. Dequeker J, et al. Among authors: geusens p. Maturitas. 1990 Apr;12(1):1-36. doi: 10.1016/0378-5122(90)90057-d. Maturitas. 1990. PMID: 2185398 Review. No abstract available.
Evaluation of the efficacy and safety of oral tiludronate in Paget's disease of bone. A double-blind, multiple-dosage, placebo-controlled study.
Reginster JY, Colson F, Morlock G, Combe B, Ethgen D, Geusens P. Reginster JY, et al. Among authors: geusens p. Arthritis Rheum. 1992 Aug;35(8):967-74. doi: 10.1002/art.1780350819. Arthritis Rheum. 1992. PMID: 1642662 Clinical Trial.
Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats.
Jiang Y, Zhao J, Genant HK, Dequeker J, Geusens P. Jiang Y, et al. Among authors: geusens p. J Bone Miner Res. 1997 May;12(5):820-31. doi: 10.1359/jbmr.1997.12.5.820. J Bone Miner Res. 1997. PMID: 9144349
Effects of low-dose long-term sodium fluoride preventive treatment on rat bone mass and biomechanical properties.
Jiang Y, Zhao J, Van Audekercke R, Dequeker J, Geusens P. Jiang Y, et al. Among authors: geusens p. Calcif Tissue Int. 1996 Jan;58(1):30-9. doi: 10.1007/BF02509543. Calcif Tissue Int. 1996. PMID: 8825236
Effect of 1alpha-vitamin D3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model.
Aerssens J, van Audekercke R, Talalaj M, Geusens P, Bramm E, Dequeker J. Aerssens J, et al. Among authors: geusens p. Endocrinology. 1996 Apr;137(4):1358-64. doi: 10.1210/endo.137.4.8625911. Endocrinology. 1996. PMID: 8625911
Effect of 1 alpha-vitamin D3 on bone strength and composition in growing rats with and without corticosteroid treatment.
Aerssens J, Van Audekercke R, Talalaj M, Van Vlasselaer P, Bramm E, Geusens P, Dequeker J. Aerssens J, et al. Among authors: geusens p. Calcif Tissue Int. 1994 Dec;55(6):443-50. doi: 10.1007/BF00298558. Calcif Tissue Int. 1994. PMID: 7895183
404 results
Jump to page
Feedback